Watch for new videos, new articles, new discussions. Thank you for being a part of our story.
Search here for cancer terms and phrases within cancerGRACE.org, and find tons of great information available on the GRACE website.
Create a profile on GRACE. Your dashboard lets you save information that is important to you, and allows you to join the conversation! Click the Profile link to return to your dashboard at any time.
Dr. H. Jack West, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, President and CEO of GRACE offers updates to our Lung Cancer Video Library.
In this video, Dr. West discusses whether immunotherapy works in patients with driver mutations like EGFR and ALK.
Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology for Johns Hopkins University School of Medicine. Dr. Levy is board certified in medical oncology and hematology by the American Board of Internal Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital.
GRACE is celebrating our 10 year anniversary! Dr. H. Jack West and the GRACE community have been helping each other since before that time but in this 10th year as a non-profit, we are pleased and humbled by the feedback and graciousness of those we have the pleasure to work with, and those who have found help and support through our GRACE site.
Dr. Doebele joined the faculty at University of Colorado Denver in July of 2008 as a member of the Thoracic Malignancies Program.
Dr. Riely is a board-certified medical oncologist who specializes in treating patients with lung cancer and thymic tumors (thymoma and thymic carcinoma). In addition to caring for men and women with these diseases, he works to develop new treatments by designing and conducting clinical trials. His clinical research focuses on the treatment of patients with thymic tumors as well as non-small cell lung cancer with specific mutations (EGFR, KRAS, BRAF, or EML4-ALK mutant non-small cell lung cancer).
Dr. Camidge is the Director of Thoracic Oncology at the University of Colorado.
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss the optimal 1st line treatment for a patient with advanced non squamous non small cell lung cancer, high PD-L1, and no driver mutation.
